Clinically Interpretable Radiomics-Based Prediction of Histopathologic Response to Neoadjuvant Chemotherapy in High-Grade Serous Ovarian Carcinoma

BACKGROUND: Pathological response to neoadjuvant treatment for patients with high-grade serous ovarian carcinoma (HGSOC) is assessed using the chemotherapy response score (CRS) for omental tumor deposits. The main limitation of CRS is that it requires surgical sampling after initial neoadjuvant chem...

Descripción completa

Detalles Bibliográficos
Autores principales: Rundo, Leonardo, Beer, Lucian, Escudero Sanchez, Lorena, Crispin-Ortuzar, Mireia, Reinius, Marika, McCague, Cathal, Sahin, Hilal, Bura, Vlad, Pintican, Roxana, Zerunian, Marta, Ursprung, Stephan, Allajbeu, Iris, Addley, Helen, Martin-Gonzalez, Paula, Buddenkotte, Thomas, Singh, Naveena, Sahdev, Anju, Funingana, Ionut-Gabriel, Jimenez-Linan, Mercedes, Markowetz, Florian, Brenton, James D., Sala, Evis, Woitek, Ramona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243357/
https://www.ncbi.nlm.nih.gov/pubmed/35785153
http://dx.doi.org/10.3389/fonc.2022.868265

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243357/
https://www.ncbi.nlm.nih.gov/pubmed/35785153
http://dx.doi.org/10.3389/fonc.2022.868265

Ejemplares similares